Precision medicine in cardiomyopathies
Cardiomyopathies manifest in various forms, ranging from genetic alterations to acquired damage. The DZHK investigates cardiomyopathies to gain a deeper understanding of them and to develop new, targeted therapies.
Why this area matters
Cardiomyopathies are among the most common causes of heart failure and arrhythmias. Their diversity makes diagnosis and treatment selection challenging. For many patients, this results in late diagnoses or ineffective therapies.
Our research approach
We study the genetic, molecular and functional basis of cardiomyopathies. Advanced imaging, biomarkers and large patient cohorts help us to describe subgroups more precisely and predict disease progression more accurately. This paves the way for more patient-specific medicine.
A key focus is the close integration of laboratory and clinical research. We swiftly test hypotheses from basic science in clinical studies. This enables new mechanisms and therapeutic approaches to be evaluated more quickly for their potential benefit to patient care.
Spokespersons
- Benjamin Meder, Heidelberg/Mannheim (Lead Spokesperson)
- Daniela Panáková, North(Spokesperson for Basic Science)
- Stephan von Haehling, Lower Saxony (Spokesperson for Clinical Science)
Are you conducting research within or outside the DZHK and would like to connect with this focus area? Please contact: